The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung cancer

Identification of Ultrasound-Sensitive Prognostic Markers of LAML and Construction of Prognostic Risk Model Based on WGCNA

Lung cancer in patients who have never smoked — an emerging disease

Combinatorial tumor suppressor inactivation efficiently initiates lung adenocarcinoma with therapeutic vulnerabilities

Frontiers Recent progress in targeted therapy for non-small cell lung cancer

Combinatorial tumor suppressor inactivation efficiently initiates lung adenocarcinoma with therapeutic vulnerabilities

Genotype-phenotype mapping of a patient-derived lung cancer organoid biobank identifies NKX2-1-defined Wnt dependency in lung adenocarcinoma - ScienceDirect

Rare molecular subtypes of lung cancer

IJMS, Free Full-Text

The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung cancer

Frontiers Recent progress in targeted therapy for non-small cell lung cancer

EGFR exon 20 insertion mutations and ERBB2 mutations in lung cancer: a narrative review on approved targeted therapies from oral kinase inhibitors to antibody-drug conjugates - Sentana-Lledo - Translational Lung Cancer Research